Lifecore Biomedical, Inc.LFCRNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P21
Within normal range
vs 5Y Ago
-32.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -157.57% |
| Q2 2025 | 159.00% |
| Q1 2025 | -360.90% |
| Q4 2024 | 83.09% |
| Q3 2024 | -639.04% |
| Q2 2024 | 340.11% |
| Q1 2024 | 39.65% |
| Q4 2023 | 82.78% |
| Q3 2023 | -598.06% |
| Q2 2023 | 81.11% |
| Q1 2023 | -22.03% |
| Q4 2022 | -63.47% |
| Q3 2022 | 91.59% |
| Q2 2022 | -354.55% |
| Q1 2022 | -306.93% |
| Q4 2021 | 250.98% |
| Q3 2021 | -322.56% |
| Q2 2021 | -49.53% |
| Q1 2021 | 266.51% |
| Q4 2020 | 88.24% |
| Q3 2020 | 4.90% |
| Q2 2020 | 12.66% |
| Q1 2020 | -148.69% |
| Q4 2019 | -37.81% |
| Q3 2019 | -276.61% |
| Q2 2019 | -5.81% |
| Q1 2019 | 534.49% |
| Q4 2018 | -35.57% |
| Q3 2018 | -105.54% |
| Q2 2018 | 151.68% |
| Q1 2018 | 679.06% |
| Q4 2017 | -121.97% |
| Q3 2017 | 3.28% |
| Q2 2017 | -43.59% |
| Q1 2017 | 32.63% |
| Q4 2016 | -40.33% |
| Q3 2016 | -22.88% |
| Q2 2016 | 121.10% |
| Q1 2016 | -1297.83% |
| Q4 2015 | -28.70% |